Differing perceptions of intervention thresholds for fracture risk: A survey of patients and doctors

Osteoporosis International

Volumn 23, Issue 8, 2012, Pages 2135-2140

  Douglas, F ^a   Petrie, K J ^a   Cundy, T ^a   Horne, A ^a   Gamble, G ^a   Grey, A ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Doctors; Fracture; Medications; Patients; Risk

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; FEMALE; FRAGILITY FRACTURE; HEALTH SURVEY; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PERCEPTION; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; ARM INJURIES; ATTITUDE OF HEALTH PERSONNEL; BONE DENSITY CONSERVATION AGENTS; CALCIUM; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; DIPHOSPHONATES; FEMALE; HIP FRACTURES; HUMANS; LEG INJURIES; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PATIENT ACCEPTANCE OF HEALTH CARE; PELVIC BONES; QUESTIONNAIRES; RISK ASSESSMENT; SHOULDER FRACTURES; SPINAL FRACTURES; TERIPARATIDE; YOUNG ADULT;

EID: 84864883290     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-011-1823-7     Document Type: Article

References (20)

1. Sambrook P, Cooper C (2006) Osteoporosis. Lancet 367:2010-2018
2. Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377:1276-1287
3. Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV (2008) Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 19:1431-1444
4. Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E (2009) FRAX and its applications to clinical practice. Bone 44:734-743
5. National Osteoporosis Foundation (2009) Clinician's guide to prevention and treatment of osteoporosis. http://www.nof.org/sites/default/files/pdfs/NOF- ClinicianGuide2009-v7.pdf. Accessed 23 Jul 2011
6. Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A (2008) Case finding for the management of osteoporosis with FRAX-assessment and intervention thresholds for the UK. Osteoporos Int 19:1395-1408
7. Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P, Wilkins M (2009) Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas 62:105-108
8. Horne R, Weinman J (1999) Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47:555-567
9. Yood RA, Mazor KM, Andrade SE, Emani S, Chan W, Kahler KH (2008) Patient decision to initiate therapy for osteoporosis; the influence of knowledge and beliefs. J Gen InternMed 23:1815-1821
10. Compston JE, Seeman E (2006) Compliance with osteoporosis therapy is the weakest link. Lancet 368:973-974
11. Schousboe JT, Dowd BE, Davison ML, Kane RL (2010) Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures. Osteoporos Int 21:1899-1909
12. Satterfield T, Johnson SM, Slovic P, Neil N, Schein JR (2000) Perceived risks and reported behaviors associated with osteoporosis and its treatment. Women Health 31:21-40
13. FRAX (2011) WHO fracture risk assessment tool. http://www. shef.ac.uk/FRAX. Accessed 7 Sept 2011
14. Steel N (2000) Thresholds for taking antihypertensive drugs in different professional and lay groups: questionnaire survey. BMJ 320:1446-1447
15. Trewby PN, Reddy AV, Trewby CS, Ashton VJ, Brennan G, Inglis J (2002) Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs. Clin Med 2:527-533
16. Bolland MJ, Grey A (2010) Disparate outcomes from applying U. K. and U.S. osteoporosis treatment guidelines. J Clin Endocrinol Metab 95:1856-1860
17. Moynihan R (2011) Overdiagnosis and the dangers of early detection. BMJ 342:d1140
18. Jarvinen TLN, Sievanen H, Kannus P, Jokihaara J, Khan KM (2011) The true cost of pharmacological disease prevention. BMJ 342:d2175
19. Seeman E, Compston J, Adachi J, Brandi ML, Cooper C, Dawson-Hughes B, Jonsson B, Pols H, Cramer JA (2007) Noncompliance: the Achilles' heel of anti-fracture efficacy. Osteoporos Int 18:711-719
20. Gigerenzer G, Edwards A (2003) Simple tools for understanding risks: from innumeracy to insight. BMJ 327:741-744